In vitro cardiac tissue model holds great potential as
a powerful
platform for drug screening. Respiratory activity, contraction frequency,
and extracellular H2O2 levels are the three
key parameters for determining the physiological functions of cardiac
tissues, which are technically challenging to be monitored in an in
situ and quantitative manner. Herein, we constructed an in vitro cardiac
tissue model on polyacrylamide gels and applied a pulsatile electrical
field to promote the maturation of the cardiac tissue. Then, we built
a scanning electrochemical microscopy (SECM) platform with programmable
pulse potentials to in situ characterize the dynamic changes in the
respiratory activity, contraction frequency, and extracellular H2O2 level of cardiac tissues under both normal physiological
and drug (isoproterenol and propranolol) treatment conditions using
oxygen, ferrocenecarboxylic acid (FcCOOH), and H2O2 as the corresponding redox mediators. The SECM results showed
that isoproterenol treatment induced enhanced oxygen consumption,
accelerated contractile frequency, and increased released H2O2 level, while propranolol treatment induced dynamically
decreased oxygen consumption and contractile frequency and no obvious
change in H2O2 levels, suggesting the effects
of activation and inhibition of β-adrenoceptor on the metabolic
and electrophysiological activities of cardiac tissues. Our work realizes
the in situ and quantitative monitoring of respiratory activity, contraction
frequency, and secreted H2O2 level of living
cardiac tissues using SECM for the first time. The programmable SECM
methodology can also be used to real-time and quantitatively monitor
electrochemical and electrophysiological parameters of cardiac tissues
for future drug screening studies.